LONDON, July 16, 2019 /PRNewswire/ -- ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, today announced that it has expanded its intellectual ...

At the most recent follow-up, subjects in the study showed a mean improvement from baseline in visual acuity of + 23 letters in the treated eye. The untreated control eyes did not show meaningful ...

Benitec Biopharma (ASX: BLT; OTCPK: BTEBD) is pleased to announce the launch of a new exploratory cellular therapy program including exosome-based delivery utilising the Company's proprietary ddRNAi ...

Angel Biotech (LON:ABH), the biopharmaceutical contract manufacturer, has signed a revised, longer-term contract with fellow AIM company Reneuron (LON:RENE) that will see it provide development and ...

SYDNEY, June 22, 2015 /PRNewswire/ -- Benitec Biopharma (ASX: BLT; OTCPK: BTEBD) is pleased to announce the launch of a new exploratory cellular therapy program including exosome-based delivery ...

ReNeuron will discontinue, out-license or dispose of all its legacy assets. (DON'T USE) Iain Ross has made an immediate mark on ReNeuron, overseeing a restructuring to reduce the British biotech’s ...

Dr David Howard, Senior Postdoctoral Research Associate working on the project using the IZON size exclusion chromatography system for exosome purification. ReNeuron Group Limited, a leading UK ...

ReNeuron receives final regulatory approval to commence landmark stroke clinical trial in UK. Guildford, UK, 10 February 2010: ReNeuron Group plc (LSE: RENE.L) today announces that the UK Gene Therapy ...

Biotech firm Reneuron Group has become the latest company to exit from the London Stock Exchange’s AIM as it continues to fight for its life after entering administration. The Welsh company, which was ...

Patient recruitment for trial with expanded neural stem cell product will begin in April. Stem cell therapeutics company ReNeuron raised about £4.7 million (almost $7.3 million) before expenses in a ...

ReNeuron Group has announced that it has signed an agreement with the Welsh Government to lease a landmark building at Pencoed Technology Park, near Cardiff, South Wales. A key element of ReNeuron’s ...